208 related articles for article (PubMed ID: 20200223)
1. Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.
de Thonel A; Ferraris SE; Pallari HM; Imanishi SY; Kochin V; Hosokawa T; Hisanaga S; Sahlgren C; Eriksson JE
Mol Biol Cell; 2010 Apr; 21(8):1423-34. PubMed ID: 20200223
[TBL] [Abstract][Full Text] [Related]
2. Nestin as a regulator of Cdk5 in differentiating myoblasts.
Pallari HM; Lindqvist J; Torvaldson E; Ferraris SE; He T; Sahlgren C; Eriksson JE
Mol Biol Cell; 2011 May; 22(9):1539-49. PubMed ID: 21346193
[TBL] [Abstract][Full Text] [Related]
3. Cdk5 regulates the organization of Nestin and its association with p35.
Sahlgren CM; Mikhailov A; Vaittinen S; Pallari HM; Kalimo H; Pant HC; Eriksson JE
Mol Cell Biol; 2003 Jul; 23(14):5090-106. PubMed ID: 12832492
[TBL] [Abstract][Full Text] [Related]
4. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
5. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta.
Odemis V; Boosmann K; Dieterlen MT; Engele J
J Cell Sci; 2007 Nov; 120(Pt 22):4050-9. PubMed ID: 17971416
[TBL] [Abstract][Full Text] [Related]
6. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
Ramos-Miguel A; García-Sevilla JA
Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
[TBL] [Abstract][Full Text] [Related]
8. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.
Kamei H; Saito T; Ozawa M; Fujita Y; Asada A; Bibb JA; Saido TC; Sorimachi H; Hisanaga S
J Biol Chem; 2007 Jan; 282(3):1687-94. PubMed ID: 17121855
[TBL] [Abstract][Full Text] [Related]
9. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
11. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
[TBL] [Abstract][Full Text] [Related]
12. A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death.
Sahlgren CM; Pallari HM; He T; Chou YH; Goldman RD; Eriksson JE
EMBO J; 2006 Oct; 25(20):4808-19. PubMed ID: 17036052
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity induces cleavage of p35 to p25 by calpain.
Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
[TBL] [Abstract][Full Text] [Related]
16. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
17. Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro.
Czapski GA; Gąssowska M; Wilkaniec A; Cieślik M; Adamczyk A
FEBS Lett; 2013 Sep; 587(18):3135-41. PubMed ID: 23954626
[TBL] [Abstract][Full Text] [Related]
18. Wnt-5a Promotes Neural Development and Differentiation by Regulating CDK5 via Ca2+/Calpain Pathway.
Shu Y; Xiang M; Zhang P; Qi G; He F; Zhang Q; Zhang Z; Lv Z; Peng X; Cai H; Tian B
Cell Physiol Biochem; 2018; 51(6):2604-2615. PubMed ID: 30562750
[TBL] [Abstract][Full Text] [Related]
19. The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.
He L; Zhang Z; Yu Y; Ahmed S; Cheung NS; Qi RZ
Cell Mol Life Sci; 2011 May; 68(9):1633-43. PubMed ID: 20976519
[TBL] [Abstract][Full Text] [Related]
20. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.
Smith PD; Mount MP; Shree R; Callaghan S; Slack RS; Anisman H; Vincent I; Wang X; Mao Z; Park DS
J Neurosci; 2006 Jan; 26(2):440-7. PubMed ID: 16407541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
